• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列人群中林奇综合征的遗传特征。

Genetic features of Lynch syndrome in the Israeli population.

作者信息

Goldberg Y, Barnes-Kedar I, Lerer I, Halpern N, Plesser M, Hubert A, Kadouri L, Goldshmidt H, Solar I, Strul H, Rosner G, Baris H N, Peretz T, Levi Z, Kariv R

机构信息

Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

出版信息

Clin Genet. 2015 Jun;87(6):549-53. doi: 10.1111/cge.12530. Epub 2014 Nov 28.

DOI:10.1111/cge.12530
PMID:25430799
Abstract

Diagnosis of Lynch syndrome (LS) may be complex. Knowledge of mutation spectrum and founder mutations in specific populations facilitates the diagnostic process. Aim of the study is to describe genetic features of LS in the Israeli population and report novel and founder mutations. Patients were studied at high-risk clinics. Diagnostics followed a multi-step process, including tumor testing, gene analysis and testing for founder mutations. LS was defined by positive mutation testing. We diagnosed LS in 242 subjects from 113 families coming from different ethnicities. We identified 54 different mutations; 13 of them are novel. Sixty-seven (59%) families had mutations in MSH2, 20 (18%) in MSH6, 19 (17%) in MLH1 and 7 (6%) in PMS2; 27% of the MSH2 mutations were large deletions. Seven founder mutations were detected in 61/113 (54%) families. Constitutional mismatch repair deficiency (CMMR-D) was identified in five families. Gene distribution in the Israeli population is unique, with relatively high incidence of mutations in MSH2 and MSH6. The mutation spectrum is wide; however, 54% of cases are caused by one of seven founder mutations. CMMR-D occurs in the context of founder mutations and consanguinity. These features should guide the diagnostic process, risk estimation, and genetic counseling.

摘要

林奇综合征(LS)的诊断可能较为复杂。了解特定人群中的突变谱和始祖突变有助于诊断过程。本研究的目的是描述以色列人群中LS的遗传特征,并报告新的和始祖突变。在高危诊所对患者进行了研究。诊断遵循多步骤流程,包括肿瘤检测、基因分析和始祖突变检测。LS通过阳性突变检测来定义。我们在来自不同种族的113个家庭的242名受试者中诊断出LS。我们鉴定出54种不同的突变;其中13种是新的。67个(59%)家庭的MSH2基因发生突变,20个(18%)家庭的MSH6基因发生突变,19个(17%)家庭的MLH1基因发生突变,7个(6%)家庭的PMS2基因发生突变;MSH2突变中有27%是大片段缺失。在61/113(54%)个家庭中检测到7种始祖突变。在5个家庭中发现了遗传性错配修复缺陷(CMMR-D)。以色列人群中的基因分布是独特的,MSH2和MSH6基因的突变发生率相对较高。突变谱很广;然而,54%的病例是由7种始祖突变之一引起的。CMMR-D发生在始祖突变和近亲结婚的背景下。这些特征应指导诊断过程、风险评估和遗传咨询。

相似文献

1
Genetic features of Lynch syndrome in the Israeli population.以色列人群中林奇综合征的遗传特征。
Clin Genet. 2015 Jun;87(6):549-53. doi: 10.1111/cge.12530. Epub 2014 Nov 28.
2
Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome.林奇综合征中的错配修复基因始祖突变与癌症易感性
Clin Genet. 2015 Jun;87(6):507-16. doi: 10.1111/cge.12529. Epub 2014 Dec 9.
3
Lynch Syndrome in high risk Ashkenazi Jews in Israel.以色列高危阿什肯纳兹犹太人中的林奇综合征。
Fam Cancer. 2014 Mar;13(1):65-73. doi: 10.1007/s10689-013-9675-2.
4
Prediction of Lynch syndrome in consecutive patients with colorectal cancer.连续性结直肠癌患者林奇综合征的预测
J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. doi: 10.1093/jnci/djn499. Epub 2009 Feb 24.
5
High frequency of exon deletions and putative founder effects in French Canadian Lynch syndrome families.法裔加拿大林奇综合征家族中外显子缺失的高频率及假定的奠基者效应。
Hum Mutat. 2009 Aug;30(8):E797-812. doi: 10.1002/humu.21056.
6
Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.鉴定与 Lynch 综合征表型相关的 MSH2 基因中新的 Alu 介导的重排。
Cancer Prev Res (Phila). 2011 Oct;4(10):1546-55. doi: 10.1158/1940-6207.CAPR-11-0227. Epub 2011 Jul 21.
7
A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.拉丁美洲疑似林奇综合征患者的临床病理和分子特征调查。
BMC Cancer. 2017 Sep 5;17(1):623. doi: 10.1186/s12885-017-3599-4.
8
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.导致 HNPCC 的 MSH6 基因中的一个阿什肯纳兹奠基者突变。
Fam Cancer. 2010 Jun;9(2):141-50. doi: 10.1007/s10689-009-9298-9.
9
A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.基于人群的遗传性非息肉病性结直肠癌研究:病理学和遗传学异质性的证据。
Clin Genet. 2013 Dec;84(6):522-30. doi: 10.1111/cge.12080. Epub 2013 Feb 7.
10
Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population.一种导致法裔加拿大人群林奇综合征的新型始祖MSH6突变的特征分析。
Clin Genet. 2015 Jun;87(6):536-42. doi: 10.1111/cge.12526. Epub 2014 Nov 22.

引用本文的文献

1
Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on I1307K and cancer risk.国际胃肠遗传肿瘤学会(InSiGHT)关于 I1307K 与癌症风险的立场声明。
J Med Genet. 2023 Nov;60(11):1035-1043. doi: 10.1136/jmg-2022-108984. Epub 2023 Apr 19.
2
Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.结直肠癌的遗传易感性:综合征、基因、遗传变异分类以及对精准医学的影响。
J Pathol. 2019 Apr;247(5):574-588. doi: 10.1002/path.5229. Epub 2019 Feb 20.
3
A Novel Initiation Codon Mutation (c.3G>T) in a Large Chinese Lynch Syndrome Family with Different Onset Age and mRNA Expression Level.
一个新的起始密码子突变(c.3G>T)在一个有不同发病年龄和 mRNA 表达水平的大型中国 Lynch 综合征家族中。
Biomed Res Int. 2018 Nov 14;2018:1460835. doi: 10.1155/2018/1460835. eCollection 2018.
4
Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel.以色列连续的阿拉伯贝都因结直肠癌患者中的先天性错配修复缺陷和林奇综合征
Fam Cancer. 2018 Jan;17(1):79-86. doi: 10.1007/s10689-017-0009-7.
5
Recurrent TP53 missense mutation in cancer patients of Arab descent.阿拉伯裔癌症患者中TP53基因复发性错义突变
Fam Cancer. 2017 Apr;16(2):295-301. doi: 10.1007/s10689-016-9951-z.